These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 31652009)
1. Oral Iron Replacement Normalizes Fibroblast Growth Factor 23 in Iron-Deficient Patients With Autosomal Dominant Hypophosphatemic Rickets. Imel EA; Liu Z; Coffman M; Acton D; Mehta R; Econs MJ J Bone Miner Res; 2020 Feb; 35(2):231-238. PubMed ID: 31652009 [TBL] [Abstract][Full Text] [Related]
2. Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice. Clinkenbeard EL; Farrow EG; Summers LJ; Cass TA; Roberts JL; Bayt CA; Lahm T; Albrecht M; Allen MR; Peacock M; White KE J Bone Miner Res; 2014 Feb; 29(2):361-9. PubMed ID: 23873717 [TBL] [Abstract][Full Text] [Related]
3. FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets. Imel EA; Hui SL; Econs MJ J Bone Miner Res; 2007 Apr; 22(4):520-6. PubMed ID: 17227222 [TBL] [Abstract][Full Text] [Related]
4. Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Farrow EG; Yu X; Summers LJ; Davis SI; Fleet JC; Allen MR; Robling AG; Stayrook KR; Jideonwo V; Magers MJ; Garringer HJ; Vidal R; Chan RJ; Goodwin CB; Hui SL; Peacock M; White KE Proc Natl Acad Sci U S A; 2011 Nov; 108(46):E1146-55. PubMed ID: 22006328 [TBL] [Abstract][Full Text] [Related]
5. Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans. Imel EA; Peacock M; Gray AK; Padgett LR; Hui SL; Econs MJ J Clin Endocrinol Metab; 2011 Nov; 96(11):3541-9. PubMed ID: 21880793 [TBL] [Abstract][Full Text] [Related]
6. Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease. Wolf M; White KE Curr Opin Nephrol Hypertens; 2014 Jul; 23(4):411-9. PubMed ID: 24867675 [TBL] [Abstract][Full Text] [Related]
7. Iron replacement ameliorates hypophosphatemia in autosomal dominant hypophosphatemic rickets: A review of the role of iron. Menon LP; Weinstein RS Bone; 2020 Feb; 131():115137. PubMed ID: 31756522 [TBL] [Abstract][Full Text] [Related]
8. Iron deficiency plays essential roles in the trigger, treatment, and prognosis of autosomal dominant hypophosphatemic rickets. Liu C; Li X; Zhao Z; Chi Y; Cui L; Zhang Q; Ping F; Chai X; Jiang Y; Wang O; Li M; Xing X; Xia W Osteoporos Int; 2021 Apr; 32(4):737-745. PubMed ID: 32995940 [TBL] [Abstract][Full Text] [Related]
9. FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets. Sun Y; Wang O; Xia W; Jiang Y; Li M; Xing X; Hu Y; Liu H; Meng X; Zhou X J Bone Miner Metab; 2012 Jan; 30(1):78-84. PubMed ID: 21710177 [TBL] [Abstract][Full Text] [Related]
10. Hypophosphatemic rickets and short stature. Davis K; Imel EA; Kelley J J Bone Miner Res; 2024 Aug; 39(7):821-825. PubMed ID: 38988138 [TBL] [Abstract][Full Text] [Related]
11. Genetic rescue of glycosylation-deficient Fgf23 in the Galnt3 knockout mouse. Ichikawa S; Gray AK; Padgett LR; Allen MR; Clinkenbeard EL; Sarpa NM; White KE; Econs MJ Endocrinology; 2014 Oct; 155(10):3891-8. PubMed ID: 25051439 [TBL] [Abstract][Full Text] [Related]
12. [Phosphate metabolism and iron deficiency]. Yokoyama K Clin Calcium; 2016 Feb; 26(2):241-9. PubMed ID: 26813504 [TBL] [Abstract][Full Text] [Related]
13. Earlier Onset in Autosomal Dominant Hypophosphatemic Rickets of R179 than R176 Mutations in Fibroblast Growth Factor 23: Report of 20 Chinese Cases and Review of the Literature. Liu C; Zhao Z; Wang O; Li M; Xing X; Hsieh E; Fukumoto S; Jiang Y; Xia W Calcif Tissue Int; 2019 Nov; 105(5):476-486. PubMed ID: 31486862 [TBL] [Abstract][Full Text] [Related]
14. Autosomal Dominant Hypophosphatemic Rickets: A Case Report and Review of the Literature. Mameli C; Sangiorgio A; Colombo V; Gambino M; Spaccini L; Cattaneo E; Zuccotti GV Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444516 [TBL] [Abstract][Full Text] [Related]
15. Iron Supplementation Associated With Loss of Phenotype in Autosomal Dominant Hypophosphatemic Rickets. Kapelari K; Köhle J; Kotzot D; Högler W J Clin Endocrinol Metab; 2015 Sep; 100(9):3388-92. PubMed ID: 26186302 [TBL] [Abstract][Full Text] [Related]
16. Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations. Imel EA; DiMeglio LA; Hui SL; Carpenter TO; Econs MJ J Clin Endocrinol Metab; 2010 Apr; 95(4):1846-50. PubMed ID: 20157195 [TBL] [Abstract][Full Text] [Related]
17. Iron and fibroblast growth factor 23 in X-linked hypophosphatemia. Imel EA; Gray AK; Padgett LR; Econs MJ Bone; 2014 Mar; 60():87-92. PubMed ID: 24325979 [TBL] [Abstract][Full Text] [Related]
18. Bone characteristics of autosomal dominant hypophosphatemic rickets patients. Liu C; Ni X; Zhao Z; Qi W; Jiang Y; Li M; Wang O; Xing X; Xia W Bone; 2023 Feb; 167():116602. PubMed ID: 36347435 [TBL] [Abstract][Full Text] [Related]
19. An autosomal dominant hypophosphatemic rickets phenotype in a Tunisian family caused by a new FGF23 missense mutation. Gribaa M; Younes M; Bouyacoub Y; Korbaa W; Ben Charfeddine I; Touzi M; Adala L; Mamay O; Bergaoui N; Saad A J Bone Miner Metab; 2010; 28(1):111-5. PubMed ID: 19655082 [TBL] [Abstract][Full Text] [Related]